inaqovi
otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - Левкемия, миелоид - Антинеопластични средства - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.
dacogen
janssen-cilag international n.v. - децитабин - Левкемия, миелоид - Антинеопластични средства - Лечение на възрастни пациенти с новодиагностицираните de novo или вторична остра миелоидна левкемия (aml) според класификацията на Световната здравна организация (СЗО), които не са кандидатки за стандартен индукционна химиотерапия.
gemcitabin ebewe 200 mg powder for solution for infusion
ebewe pharma ges.m.b.h. nfg.kg - Гемцитабин - 200 mg powder for solution for infusion
gemcitabin ebewe 1000 mg powder for solution for infusion
ebewe pharma ges.m.b.h. nfg.kg - Гемцитабин - 1000 mg powder for solution for infusion
gemcitabine - tchaikapharma 200 mg powder for solution for infusion
Чайкафарма Висококачествените Лекарства" АД" - 200 mg powder for solution for infusion
gemcitabine - tchaikapharma 1000 mg powder for solution for infusion
Чайкафарма Висококачествените Лекарства" АД" - 1000 mg powder for solution for infusion
gemcitabine pharma resourses 200 mg powder for solution for infusion
pharma resources gmbh - 200 mg powder for solution for infusion
gemcitabine pharma resourses 1000 mg powder for solution for infusion
pharma resources gmbh - 1000 mg powder for solution for infusion
gemcitabine csc 200 mg powder for solution for infusion
gp pharm, s.a. - 200 mg powder for solution for infusion
gemcitabine csc 1 000 mg powder for solution for infusion
gp pharm, s.a. - 1 000 mg powder for solution for infusion